Psychosocial Reaction Patterns to Alopecia in Female Patients with Gynecological Cancer undergoing Chemotherapy

  • Published : 2015.03.04


This study aims to clarify the psychosocial reactions of female patients with gynecological cancer undergoing chemotherapy and in the process of suffering from alopecia and to examine their nursing support. The target group comprised female patients who had received two or more cycles of chemotherapy, were suffering from alopecia, and were aged 30-65. Data were collected from semi-structured interviews, conducted from the time the patients were informed by their doctors that they might experience alopecia due to chemotherapy to the time they actually experienced alopecia and until they were able to accept the change. Inductive qualitative analysis was employed to close in on the subjective experiences of the cancer patients. The results showed the existence of six phases in the psychosocial reactions in the process of alopecia: phase one was the reaction after the doctor's explanation; phase two was the reaction when the hair starts to fall out; phase three was the reaction when the hair starts to intensely fall out; phase four was the reaction when the hair has completely fallen out; phase five was the reaction to behavior for coping with alopecia; and phase six was the reaction to change in interpersonal human relationships. The results also made it clear that there are five types of reaction patterns as follows: 1) treatment priority interpersonal relationship maintenance type; 2) alopecia agitated interpersonal relationship maintenance type; 3) alopecia agitated interpersonal relationship reduction type; 4) alopecia denial interpersonal relationship reduction type; and 5) alopecia denial treatment interruption type. It is important to find out which of the five types the patients belong to early during treatment and provide support so that nursing intervention that suits each individual can be practiced. The purpose of this study is to make clear the process in which patients receiving chemotherapy come to accept alopecia and to examine evidence-based nursing care on patients with strong mental distress from alopecia.


  1. Batchelor, D (2001), Hair and cancer chemotherapy: consequences and nursing care-a literature study, Eur J Cancer Care, 10, 147-163.
  2. Bello LK, McIntire SN (1995), Body image disturbances in young adults with cancer: implication for the oncology clinical nurse specialist, Cancer Nurs, 18, 138-2.
  3. Bernard M, Brignone M, Adehossi A, et al (2011). Perception of alopecia by patients requiring chemotherapy for nonsmall- cell lung cancer: a willingness to pay study. Lung Cancer, 72, 114-8.
  4. Can G, Demir M, Erol O, Aydiner A (2013). A comparison of men and women's experiences of chemotherapy of chemotherapy-induced alopecia. Eur J Oncol Nurs, 17, 255-60.
  5. Carelle N, Piotto E, Bellanger A, et al. (2002). Changing patients of the side effects of cancer chemotherapy. Cancer, 95, 155-163.
  6. Dean, J, Salmon, S. l (1979). Prevention of doxorubicin-induced hair loss with scalp hypothermia. N Engl J Med, 30, 1427-9.
  7. Ekwall EM, Nygren LM, Gustafsson AO, Sorbe BG (2013). Determination of the most effective cooling temperature for the prevention of chemotherapy-induced alopecia. Molec Clinical Oncol, 1, 1065-71.
  8. Frith H, Harcourt D, Fussell A (2007). Anticipating an altered appearance: Women undergoing chemotherapy treatment for breast cancer. Eur J Oncol Nursing, 11, 385-391.
  9. Fujisaki K (1996). Development of "Body Image Assessment Tool." J Japan Acad Health Behavioral Sci, 5, 178-99.
  10. Gregory RP, Cooke T, Middleton J, et al (1982). Prevention of doxorubicin-induced Alopecia by scalp hypothermia: Relation to degree of cooling. Br Med J, 284, 1674
  11. Hamada M, Ohji T, Fukui R, Tanno K, Kasamatsu T, Ebina M (2007). Coping behavior and feelings in middle-aged men who have experienced hair loss induced by cancer chemotherapy. Kobe City College Nursing, 11, 19-26.
  12. Hilton S, Hunt K, Emslie C, et al (2008). Have men been overlooked? A comparison of young men and women experiences chemotherapy of chemotherapy-induced alopecia. Psycho-oncology, 17, 577-583.
  13. Kanda K, Iida M, Nakamura M (1998). Study on the gustatory change of cancer chemotherapy patients: Part II the relationship between chemotherapy side effects and gustatory change. Kitakanto Medical J, 6, 455-459.
  14. Kaoru Fujisaki (2000). An integrative literature review about body-image intervention program and effects-analysis and synthesis of evaluation research using substruction method. J Nurs Res, 33, 73-87.
  15. Kazuko I, Junko I, Mami N, et al (2004). Concerns and treatment continuation factor of outpatient chemotherapy of breast on the patients daily life. Ann Gunma University School Health Sciences, 25, 42-53.
  16. Keiko M, Noriko M, Maki M, et al (2013). The effects of chemotherapy-induced alopecic experience on daily living. J Nursing Invest, 11, 14-23.
  17. Kim IR, Cho J, Choi EK, et al (2012). Perception, attitudes, preparedness, and experience of chemotherapy-induced alopecia among breast cancer patients: a qualitative study. Asian Pac J Cancer Prev, 13, 1383-8.
  18. Komen MM, Smorenburg CH, Van den hurk CJ, Nortier JW (2013). Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia. The Oncologist. 885-91.
  19. Lemieux J, Maunsell E, Provencher L (2008). Chemotherapyinduced alopecia and effects on quality of life among women with breast cancer: a literature review. Psycho-Oncol, 17, 317-28.
  20. McGarvey EL, Leon-Verdin M, Baum LD, et al (2011). An evaluation of a computer imaging program to prepare women for chemotherapy-related alopecia. Psycho-Oncol, 19, 756-66.
  21. Mitsuko M, Fusae M, Toshie K, et al (1992). Longitudinal studies of psychological adjustment for mastectomy patients (1)-Psychological reactions from pre-surgery to 3 years postsurgery, J Japan Soc Nursing Res, 15, 20-28.
  22. Mols F, Van den Hurk CJ, Vingerhorts AJ, et al (2008). Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations. Support Care Cancer, 17, 181-9.
  23. Nahoko S, Mitiko M (2009). Pain perceived by outpatients receiving chemotherapy for cancer. J Jpn Soc Cancer Nurs, 23, 53-60.
  24. Nolte S, Donnelly J, Kelly S, Conley P, Cobb R (2006). A randomized clinical trial of a videotape in intervention for woman with chemotherapy-induced alopecia: a gynecologic oncology group study. Oncol Nurs Forum, 33, 305-311.
  25. Roe, H (2011). Chemotherapy-induced alopecia: advice and support for hair loss. Br J Nurs, 9, 4-11.
  26. Satoko Nagata (2001). Research on Factors Related to the Psychosocial Adjustment of Adult Outpatients with Hematological Malignancies. Journal of Japan Society of Cancer Nursing, 15, 5-15.
  27. Vandegrift KV, CRNI (1994). The Development of an Oncology Alopecia Program. J Intravenous Nursing, 17, 79-82.
  28. Van den Hurk CJ, Mols F, Vingerhoets AJ, et al (2010). Impact of alopecia and scalp cooling on the wellbeing of breast cancer patients. Psycho-Oncol, 19, 701-809.
  29. Van den Hurk CJ, Peerbooms M, van de Poll-Franse LV, et al (2012). Scalp cooling for hair preservation and associated characteristics in 1441 chemotherapy patients- results of the Dutch Scalp Cooling Registry. Acta Oncol, 51, 497-504.
  30. Van den Hurk CJ, Breed WP, Nortier JW (2012). Short postinfusion scalp cooling time in the prevention of docetaxelinduced alopecia. Support Care Cancer, 20, 3255-60.
  31. Williams J, Wood C, Cunningham-Warburton C (1999). A narrative study of chemotherapy-induced alopecia. Oncology Nursing Forum, 26, 1463-9.

Cited by

  1. Gender differences in cancer-related distress in Japan: a retrospective observation study vol.10, pp.1, 2016,
  2. Antineoplastics/epirubicin vol.1591, pp.1, 2016,